New Research from the CWMH: Data on the Reproductive Safety of Vortioxetine
New prospective data on 56 first-trimester vortioxetine exposures found no major malformations, offering reassuring but still preliminary reproductive safety information.
New Research from the CWMH: Vortioxetine Effective for Depression and Menopausal Symptoms
As women transition into the menopause, they experience a constellation of symptoms including vasomotor symptoms (hot flashes and night sweats), sleep disruption, problems with sexual functioning, and cognitive impairment. Women may also be more [...]
Weekly Roundup for October 27, 2017: Recent Publications in Women’s Mental Health
This week, we have two studies from the Center for Women’s Mental Health -- one looking at risk for gestational diabetes in women treated with second generation antipsychotic medications during pregnancy and the other on [...]